David A. Robins

David Robins has been instrumental in expanding DavosPharma from strictly manufacturing and marketing of small molecule building blocks for active substances to a full-service provider. Under his leadership, DavosPharma now supports all manufacturing, biology, and regulatory needs for commercial and IND drug development. Prior to joining Davos, Mr. Robins was a lead Process Engineer at Bristol-Myers Squibb where he was responsible for the scale-up and tech transfer of several late-stage and commercial drugs. Mr. Robins received his B.S. in Engineering Chemistry from Queen’s University in Kingston, Ontario, and his M.S. in Chemical Engineering from Syracuse University.